INTANGIBLE ASSETS (Details Narrative)	3 Months Ended		6 Months Ended
	Jun. 30, 2017 USD ($) Number	Jun. 30, 2016 USD ($)	Jun. 30, 2017 USD ($) Number	Jun. 30, 2016 USD ($)
Finite-Lived Intangible Assets [Line Items]
Amortization expense | $	$ 17,789	$ 13,409	$ 33,888	$ 24,643
Number of issued patents	17		17
Approved Hormone Therapy Drug Candidate Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Useful Life			20 years
Utility Patent Progesterone and Estradiol Products [Member]
Finite-Lived Intangible Assets [Line Items]
Number of issued patents	13		13
Utility Patent TX-004HR [Member]
Finite-Lived Intangible Assets [Line Items]
Number of issued patents	2		2
Utility Patent Pipeline Transdermal Patch Technology [Member]
Finite-Lived Intangible Assets [Line Items]
Number of issued patents	1		1
Opera Software Patent [Member]
Finite-Lived Intangible Assets [Line Items]
Number of issued patents	1		1